
Samsung Tops $750 Billion Market Cap, Bets on AI to Reclaim Tech Leadership
Samsung Electronics has surpassed a $750 billion market capitalization, becoming the first South Korean company to reach the
Curated content that matters
Explore stories across diverse categories

Samsung Electronics has surpassed a $750 billion market capitalization, becoming the first South Korean company to reach the

Paris Baguette, a South Korea–based bakery café chain operated by SPC Group that sells breads, pastries and coffee

Hyundai Motor is pressing ahead with its Middle East expansion, strengthening strategic ties with Public Investment Fund as

South Korean cryptocurrency exchange Bithumb is facing escalating regulatory pressure after receiving a record fine and partial business
Photo=G-Dragon SNS K-pop star G-Dragon has formally confirmed that BigBang will reunite for a 20th-anniversary comeback this year, marking a milestone return for one of South Korea’s most influential pop groups. According to agency Galaxy Corporation, G-Dragon made the announcement during his first solo fan meetings held Feb. 6–8 (local time) at the KSPO Dome in Seoul’s Olympic Park. Addressing
Photo=Google Google’s generative-artificial-intelligence service Gemini is gathering momentum in South Korea, surpassing 100,000 monthly active users for the first time and signaling that competition in one of Asia’s most wired markets is beginning to broaden beyond OpenAI’s ChatGPT. Gemini recorded 123,647 monthly users in January, according to data released Monday by mobile-analytics firm IGAWorks. That marked the service’s highest level
(Photo=bibigo) The frozen-food aisle at Dollar Tree no longer serves only as a repository for basic, low-cost meals. As dollar stores expand their role in everyday grocery shopping, frozen sections have become one of the most tightly contested parts of the store, governed by strict price ceilings and relentless pressure for fast turnover. In that setting, survival depends less on
(Photo=Lotte Biologics) As pharmaceutical companies place growing emphasis on domestic production, regulatory certainty and supply-chain resilience, competition among contract drug manufacturers in the United States is increasingly being shaped by operational credibility rather than sheer capacity. For CDMOs seeking to win business from global drugmakers, the ability to operate smoothly under U.S. regulatory scrutiny has become a decisive differentiator. That
(Photo=Kolmar Korea R&D Complex) Kolmar Korea has emerged with a sweeping legal win in its yearslong battle over the alleged theft of proprietary sunscreen technology, after Korean courts affirmed both criminal guilt and civil responsibility and ordered the opposing side to bear the full cost of litigation. The decision marks one of the clearest judicial endorsements yet of a domestic